Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Dec;85(12):1824–1830. doi: 10.1054/bjoc.2001.2196

The surgical management of women with ovarian cancer in the south west of England

A Olaitan 1, J Weeks 2, A Mocroft 3, J Smith 1, K Howe 1, J Murdoch 1
PMCID: PMC2364011  PMID: 11747321

Abstract

The surgical management of epithelial ovarian cancer in the South West of England was studied in the two years 1997–1998 in order to determine the factors that influence the outcome of surgery and to provide a baseline from which to assess the effect of centralisation of cancer services. All hospitals in the South West region of England participating in the Regional Cancer Organisation's longitudinal study of outcomes in gynaecological malignancies are included. Six hundred and eighty-two patients with epithelial ovarian cancer were registered with the RCO in the two-year study period. Five hundred and ninety-five women were offered primary cytoreductive surgery of which 438 were said to be optimally cytoreduced. Applying multivariate models to analyse the outcome of surgery, older patients (OR = 0.82 per 5-year increase in age, P = 0.0003), patients treated in hospitals managing fewer than ten cases of ovarian cancer per year (OR = 1.92, P = 0.02) and patients with FIGO stage 3 (OR = 0.02, P < 0.0001) or 4 (OR = 0.002, P < 0.0001) disease were less likely to be optimally cytoreduced. Gynaecological oncologists were 2.06 times more likely to attain optimal cytoreduction when compared to general gynaecologists and this was statistically significant (P = 0.01). The results from this study support the argument that limiting surgery for ovarian malignancy to specialised surgeons improves the extent of cytoreductive surgery. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: ovarian cancer, surgery, cytoreduction, gynaecological oncologist

Full Text

The Full Text of this article is available as a PDF (114.5 KB).

Footnotes

On behalf of: South and West Tumour Panel for Gynaecological Cancer R Anderson, P Bliss, I Boyd, T Clarke, R Counsell, J Cullimore, F Daniel, A Falconer, E Gilby, J Giles, J Graham, L Hirschowitz, A Hong, N Johnson, V Laurence, R Marshall, JB Murdoch, J Orford, JN Renninson, J Richardson, G Swingler

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Hunter R. W., Alexander N. D., Soutter W. P. Meta-analysis of surgery in advanced ovarian carcinoma: is maximum cytoreductive surgery an independent determinant of prognosis? Am J Obstet Gynecol. 1992 Feb;166(2):504–511. doi: 10.1016/0002-9378(92)91658-w. [DOI] [PubMed] [Google Scholar]
  2. Högberg T., Carstensen J., Simonsen E. Treatment results and prognostic factors in a population-based study of epithelial ovarian cancer. Gynecol Oncol. 1993 Jan;48(1):38–49. doi: 10.1006/gyno.1993.1007. [DOI] [PubMed] [Google Scholar]
  3. Jackson S., Murdoch J., Howe K., Bedford C., Sanders T., Prentice A. The management of cervical carcinoma within the south west region of England. Expert Tumour Panel. Br J Obstet Gynaecol. 1997 Feb;104(2):140–144. doi: 10.1111/j.1471-0528.1997.tb11033.x. [DOI] [PubMed] [Google Scholar]
  4. Junor E. J., Hole D. J., Gillis C. R. Management of ovarian cancer: referral to a multidisciplinary team matters. Br J Cancer. 1994 Aug;70(2):363–370. doi: 10.1038/bjc.1994.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Junor E. J., Hole D. J., McNulty L., Mason M., Young J. Specialist gynaecologists and survival outcome in ovarian cancer: a Scottish national study of 1866 patients. Br J Obstet Gynaecol. 1999 Nov;106(11):1130–1136. doi: 10.1111/j.1471-0528.1999.tb08137.x. [DOI] [PubMed] [Google Scholar]
  6. Kehoe S., Powell J., Wilson S., Woodman C. The influence of the operating surgeon's specialisation on patient survival in ovarian carcinoma. Br J Cancer. 1994 Nov;70(5):1014–1017. doi: 10.1038/bjc.1994.440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Marsoni S., Torri V., Valsecchi M. G., Belloni C., Bianchi U., Bolis G., Bonazzi C., Colombo N., Epis A., Favalli G. Prognostic factors in advanced epithelial ovarian cancer. (Gruppo Interregionale Cooperativo di Oncologia Ginecologica (GICOG)). Br J Cancer. 1990 Sep;62(3):444–450. doi: 10.1038/bjc.1990.315. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Nguyen H. N., Averette H. E., Hoskins W., Sevin B. U., Penalver M., Steren A. National survey of ovarian carcinoma. VI. Critical assessment of current International Federation of Gynecology and Obstetrics staging system. Cancer. 1993 Nov 15;72(10):3007–3011. doi: 10.1002/1097-0142(19931115)72:10<3007::aid-cncr2820721024>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]
  9. Trimbos J. B., Hellebrekers B. W., Kenter G. G., Peters L. A., Zwinderman K. H. The long learning curve of gynaecological cancer surgery: an argument for centralisation. BJOG. 2000 Jan;107(1):19–23. doi: 10.1111/j.1471-0528.2000.tb11573.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES